1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
Avanza Healthcare by Samuelsson & Hult
Fee
1.25%
ISIN
SE0019912502
Holdings
25
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Avanza Healthcare, we have 28 holdings where UnitedHealth is the largest holding (8.79), followed by Eli Lilly (7.45) and Novo Nordisk (6).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Avanza Healthcare.
| UBS Lux Equity Fund Biotech USD | Avanza Healthcare |
|---|---|
|
10.04 % |
 8.79 % |
|
9.9 % |
7.45 % |
|
9.21 % |
 6 % |
|
6.54 % |
 5.71 % |
|
5.52 % |
  4.46 % |
|
4.66 % |
4.44 % |
|
4.32 % |
3.69 % |
|
4.13 % |
3.36 % |
|
3.75 % |
3.29 % |
|
3.28 % |
 3.02 % |
| - |
2.91 % |
| - |
2.87 % |
| - |
2.84 % |
| - |
2.83 % |
| - |
2.73 % |
| - |
 2.56 % |
| - |
2.01 % |
| - |
1.76 % |
| - |
1.73 % |
| - |
1.27 % |
| - |
1.22 % |
| - |
1.17 % |
| - |
1.16 % |
| - |
1.13 % |
| - |
1.08 % |
The list of fund holdings was last updated on April 17, 2025.
